Clinical Trials Directory

Trials / Unknown

UnknownNCT03324867

The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.

The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
316 (estimated)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Decline in cognitive function after surgery occurs most commonly in older patients and patients undergoing major surgeries, such as heart surgery. Postoperative Cognitive Dysfunction (POCD) may last a prolonged period of time while Postoperative Delirium (POD) is a more acute disturbance in attention, awareness and cognition. The cause of POCD and POD are not fully understood, however some of the pathophysiology of POCD is similar to that of Alzheimer's disease (AD). Insulin given intravenously during heart surgery has been shown to preserve short and long-term memory function after the operation. Clinical trials further demonstrated that insulin given via the nose (intranasal) improves memory performance of patients with AD or cognitive impairment suggests that intranasal insulin also could be a therapeutic option for POCD and POD. This study is designed to examine the effect intranasal insulin on POCD and POD. The goal is to investigate whether administration of intranasal insulin during and after heart surgery improves cognitive function postoperatively.

Conditions

Interventions

TypeNameDescription
DRUGRegular insulin40 IU of Humulin-R to be administered via nose using metered nasal dispenser prior to surgery, and up to 7 days after surgery.
DRUGNormal Saline Flush, 0.9% Injectable SolutionPlacebo: Normal Saline to be administered via nose using metered nasal dispenser prior to surgery, and up to 7 days after surgery

Timeline

Start date
2022-04-01
Primary completion
2023-04-01
Completion
2023-04-01
First posted
2017-10-30
Last updated
2021-01-26

Source: ClinicalTrials.gov record NCT03324867. Inclusion in this directory is not an endorsement.